Sep 1, 2008
By:
Sarah Houlton
|
In order to take a big step forward, GSK looks to employ smaller licensing deals and business units
Aug 1, 2008
By:
Sarah Houlton
|
Britain's new approach to drug pricing isn't as bad as the industry feared.
Jun 1, 2008
By:
Sarah Houlton
|
EU makes plans to police its supply chain
Apr 1, 2008
By:
Sarah Houlton
|
Can ceasing trade sales and finding funding help UK biotechs became an industry in their own right?
UK agency taking the heat for slow evaluations and failing to consider societal benefits of new drugs
Mar 1, 2008
By:
Sarah Houlton
|
UK agency takes the heat for slow evaluations and failing to consider societal benefits of new drugs
UK agency worries that new pharma single-supplier practice will mean higher costs for NHS
Feb 1, 2008
By:
Sarah Houlton
|
Will the sole-wholesaler approach mean higher costs for NHS?
Pharma defends itself against claims made in charity's report on drug access for the world's poor
Jan 1, 2008
By:
Sarah Houlton
|
Pharma defends itself against claims made in charity's report on drug access for the world's poor
Will a new health council speed the introduction of innovative medicines in the United Kingdom?
Dec 1, 2007
By:
Sarah Houlton
|
One of industry's main complaints is that delaying the introduction of new medicines is a particularly simple way of saving money
Will CROs continue to operate in India, or will Novartis' pullout send them farther East?
Nov 1, 2007
By:
Sarah Houlton
|
Will CROs continue to operate in India, or will Novartis' pullout send them farther East?
